1-20 of 30
Michela Ceccolini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combining Gene Expression Profiling and Integrated Multidisciplinary Approaches to Improve Prognosis Prediction in Multiple Myeloma

Claudio Cerchione, Nour Alassi, Davide Nappi, Chiara Servili, Emanuela Scarpi, Delia Cangini, Sonia Ronconi, Michela Ceccolini, Matteo Paganelli, Luigi Coppola, Giacomo Feliciani, Alice Rossi, Fabiana Mammoli, Nicola Normanno, Gerardo Musuraca, Giorgia Simonetti, Giovanni Martinelli, Matteo Marchesini
Journal: Blood
Blood (2024) 144 (Supplement 1): 6838.
https://doi.org/10.1182/blood-2024-203211
Published: 2024
Journal Articles

Multiple Myeloma and Smoldering Myeloma: Prospective Evaluation of 3 T Whole Body MRI and 18F-FDG PET/CT and Their Impact on Clinical Management

Claudio Cerchione, Davide Bezzi, Davide Nappi, Matteo Marchesini, Andrea Prochowski Iamurri, Paola Caroli, Arrigo Cattabriga, Delia Cangini, Giacomo Feliciani, Emiliano Loi, Federica Matteucci, Domenico Barone, Sonia Ronconi, Michela Ceccolini, Gerardo Musuraca, Nicola Normanno, Giovanni Martinelli, Alice Rossi
Journal: Blood
Blood (2024) 144 (Supplement 1): 3326.
https://doi.org/10.1182/blood-2024-211380
Published: 2024
Journal Articles

Pre-Existing Myeloid Subclones May Account for a Subset of Acute Myeloid Leukemias and Myelodysplastic Neoplasms in Patients with Pre-Existing or Contemporary Lymphoid Disorders

Agnese Mattei, Giovanni Marconi, Sonia Ronconi, Delia Cangini, Michela Ceccolini, Claudio Cerchione, Irene Zacheo, Maria Benedetta Giannini, Marianna Norata, Giovanni Martinelli, Anna Ferrari, Maria Teresa Bochicchio, Martina Ghetti, Matteo Marchesini, Giorgia Simonetti, Gerardo Musuraca, Davide Nappi
Journal: Blood
Blood (2023) 142 (Supplement 1): 1475.
https://doi.org/10.1182/blood-2023-186760
Published: 2023
Journal Articles

Pegfilgrastim Versus Filgrastim in the Supportive Care of Heavily Pretreated Multiple Myeloma in Treatment with Pomalidomide-Dexamethasone

Claudio Cerchione, Davide Nappi, Gerardo Musuraca, Sonia Ronconi, Delia Cangini, Michela Ceccolini, Giovanni Martinelli
Journal: Blood
Blood (2022) 140 (Supplement 1): 13248–13249.
https://doi.org/10.1182/blood-2022-170561
Published: 2022
Journal Articles

Chemo or Chemo-Free Regimens in Heavily Pretreated Multiple Myeloma? Role of Bendamustine-Bortezomib-Dexamethasone (BVD) in NOVEL Agents' Era

Claudio Cerchione, Lucio Catalano, Davide Nappi, Anna Emanuele Pareto, Gerardo Musuraca, Sonia Ronconi, Michela Ceccolini, Giovanni Martinelli, Fabrizio Pane
Journal: Blood
Blood (2022) 140 (Supplement 1): 12585–12586.
https://doi.org/10.1182/blood-2022-170484
Published: 2022
Journal Articles

Pomalidomide-Dexamethasone in the Management of Heavily Pretreated Multiple Myeloma

Claudio Cerchione, MD PhD, Lucio Catalano, Davide Nappi, Anna Emanuele Pareto, Gerardo Musuraca, MD, Alessandro Lucchesi, MD, Sonia Ronconi, Michela Ceccolini, MD, Delia Cangini, Maria Benedetta Giannini, MD, Valeria Di Battista, Giorgia Simonetti, PhD, Andrea Ghelli Luserna Di Rorà, PhD, Fabrizio Pane, Giovanni Martinelli, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-143143
Published: 2020
Journal Articles

Unravel Inter-Tumor and Intra-Tumor Heterogeneity of Digitally Sorted Single Hodgkin and Reed Sternberg Cells Using Genome-Wide Copy Number Profiling

Chiara Mangano, PhD, Petrini Edoardo, PhD, Marianna Garonzi, PhD, Rossana Lanzellotto, PhD, Francesca Marzia Papadopulos, PhD, Chiara Bolognesi, Genny Buson, PhD, Alberto Ferrarini, PhD, Claudio Forcato, PhD, Giovanni Martinelli, MD, Francesca Fontana, Michela Ceccolini, MD, Francesco Fabbri, Pietro Fici, PhD, Giulia Gallerani, PhD, Cecilia Simonelli, MD, Gianni Medoro, PhD, Nicolò Manaresi, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1568.
https://doi.org/10.1182/blood-2018-99-109989
Published: 2018
Journal Articles

Patologic IL 17 Producing Helper T Cells In Acute Myeloid Leukemia Patients

Gerardo Musuraca, MD, PhD, Serena De Matteis, Roberta Napolitano, Francesco Fabbri, Delia Cangini, MD, Michela Ceccolini, MD, Maria Benedetta Giannini, MD, Alessandro Lucchesi, MD, Sonia Ronconi, MD, Cristina Papayannidis, MD, Viviana Guadagnuolo, Giovanni Martinelli, MD, Paolo Savini, MD, Monica Tani, MD, Patrizia Tosi, MD, Dino Amadori, MD, Pier Paolo Fattori, MD, Wainer Zoli, Silvia Carloni
Journal: Blood
Blood (2013) 122 (21): 2289.
https://doi.org/10.1182/blood.V122.21.2289.2289
Published: 2013
Journal Articles

Long Term Efficacy of Percutaneous Vertebroplasty in Multiple Myeloma (MM) Patients: Experience of the “Gruppo Ematologico Di Romagna” (GER)

Patrizia Tosi, MD, Annalia Molinari, MD, Michele Sintini, MD, Anna Merli, MD, Michela Ceccolini, MD, Manuela Imola, MD, Paolo Savini, MD, Silvana Pasini, MD, Anna M Mianulli, MD, Barbara Castagnari, MD, Pier P Fattori, MD, Giovanni Martinelli, MD, PhD, Alfonso Zaccaria
Journal: Blood
Blood (2011) 118 (21): 5123.
https://doi.org/10.1182/blood.V118.21.5123.5123
Published: 2011
Journal Articles

Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)

Paola Tacchetti, MD, Carolina Terragna, PhD, Gioacchino Catania, MD, Magda Marcatti, MD, Andrea Nozza, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Catello Califano, MD, Anna Baraldi, MD, Andrea Gallamini, MD, Pellegrino Musto, MD, Patrizia Tosi, MD, Piero Galieni, MD, Annalisa Pezzi, Statistician, Francesco Lanza, MD, Michela Ceccolini, MD, Filippo Ballerini, MD, Lucio Catalano, MD, Clotilde Cangialosi, MD, Antonio Lazzaro, MD, Giorgio Paladini, MD, Ruggero Mozzana, MD, Beatrice Anna Zannetti, MD, Graziella Pinotti, MD, Francesca Elice, MD, Michele Baccarani, MD, Mario Boccadoro, MD, Guido Cavaletti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 1821.
https://doi.org/10.1182/blood.V118.21.1821.1821
Published: 2011
Journal Articles

Prognostic Impact of Cytogenetic Abnormalities On Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated with Thalidomide-Dexamethasone Incorporated Into Double Autologous Stem-Cell Transplantation: An Analysis of 593 Patients

Elena Zamagni, Nicoletta Testoni, Carolina Terragna, Paola Tacchetti, Mauro Fiacchini, Francesca Patriarca, Patrizia Tosi, Francesco Di Raimondo, Giulia Marzocchi, Maria Teresa Petrucci, Lucio Catalano, Sandra Durante, Silvestro Volpe, Monica Galli, Luciano Masini, Antonio Ledda, Annamaria Brioli, Claudia Crippa, Alessandro Gozzetti, Franco Narni, Catello Califano, Claudia Cellini, Sara Bringhen, Giuliana Leopardi, Lucia Pantani, Michela Ceccolini, Massimo Offidani, Giulia Perrone, Beatrice Anna Zannetti, Michele Baccarani, MD, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 3562.
https://doi.org/10.1182/blood.V116.21.3562.3562
Published: 2010
Journal Articles

Incorporation of Thalidomide-Dexamethasone (Thal-Dex) into up-Front Double Autologous Stem-Cell Transplantation (ASCT) for multiple Myeloma: Final analysis of phase II “Bologna 2002” Study.

Elena Zamagni, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Paola Tacchetti, M.D., Chiara Nicci, B.S., Patrizia Tosi, M.D., Mauro Fiacchini, M.D., Francesca Patriarca, M.D., Francesco Di Raimondo, M.D., Lucio Catalano, M.D., Francesco Casulli, M.D., Silvestro Volpe, M.D., Luciano Masini, M.D., Antonio Ledda, M.D., Annamaria Brioli, M.D., Delia Cangini, M.D., Alessandro Gozzetti, M.D., Catello Califano, M.D., Claudia Cellini, M.D., Affra Carubelli, M.D., Alessandro Petrucci, M.D., Giuliana Leopardi, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Massimo Offidani, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, M.D.
Journal: Blood
Blood (2009) 114 (22): 349.
https://doi.org/10.1182/blood.V114.22.349.349
Published: 2009
Journal Articles

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Patrizia Tosi, M.D., Alessandro Petrucci, M.D., Lucia Pantani, M.D., Elena Zamagni, Paola Tacchetti, M.D., Giulia Perrone, M.D., Annamaria Brioli, M.D., Michela Ceccolini, M.D., Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2009) 114 (22): 4885.
https://doi.org/10.1182/blood.V114.22.4885.4885
Published: 2009
Journal Articles

Thalidomide-Dexamethasone as Induction Therapy Prior to Autologous Stem-Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Failure.

Patrizia Tosi, M.D., Elena Zamagni, Paola Tacchetti, M.D., Michela Ceccolini, M.D., Giulia Perrone, M.D., Annamaria Brioli, M.D., Lucia Pantani, M.D., Alessandro Petrucci, M.D., Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2009) 114 (22): 4934.
https://doi.org/10.1182/blood.V114.22.4934.4934
Published: 2009
Journal Articles

Economic and Social Burden of Multiple Myeloma in Italy: The Co.Mi.M. Study

Maria Teresa Petrucci, Elisabetta Calabrese, Anna Levi, Vincenzo Federico, Michela Ceccolini, Rita Rizzi, Alessandro Gozzetti, Patrizia Falco, Maria Caterina Cavallo, Simone Gerzelli, Mario Boccadoro, Francesco Lauria, Vincenzo Liso, Michele Cavo, Robert Foa
Journal: Blood
Blood (2008) 112 (11): 2393.
https://doi.org/10.1182/blood.V112.11.2393.2393
Published: 2008
Journal Articles

Bortezomib-Thalidomide-Dexamethasone as Primary Induction Therapy for Newly Diagnosed Multiple Myeloma Significantly Decreases Bone Resorption While Sparing Bone Formation as Compared to Thalidomide-Dexamethasone

Patrizia Tosi, MD, Elena Zamagni, MD, Paola Tacchetti, MD, Giulia Perrone, MD, Michela Ceccolini, MD, Anna Maria Brioli, MD, Maria Caterina Pallotti, MD, Lucia Pantani, MD, Alessandro Petrucci, MD, Michele Baccarani, Michele Cavo, MD
Journal: Blood
Blood (2008) 112 (11): 5117.
https://doi.org/10.1182/blood.V112.11.5117.5117
Published: 2008
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Superior Complete Response Rate and Progression-Free Survival after Autologous Transplantation with up-Front Velcade-Thalidomide- Dexamethasone Compared with Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Franco Narni, M.D., Sara Bringhen, M.D., Vittorio Montefusco, M.D., Massimo Offidani, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Ausilia Gorgone, M.D., Annamaria Brioli, M.D., Maria Caterina Pallotti, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Antonio Ledda, M.D., Tommaso Caravita, M.D., Antonietta Falcone, M.D., Alfonso Zaccaria, M.D., Giulia Perrone, M.D., Alessandro Petrucci, M.D., Antonio Palumbo, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 158.
https://doi.org/10.1182/blood.V112.11.158.158
Published: 2008
Journal Articles

Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) in Preparation for Autologous Stem-Cell (SC) Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM).

Michele Cavo, MD, Francesca Patriarca, M.D., Paola Tacchetti, M.D., Monica Galli, M.D., Giulia Perrone, M.D., Maria Teresa Petrucci, M.D., Annamaria Brioli, M.D., Sara Bringhen, M.D., Lucia Pantani, M.D., Patrizia Tosi, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Francesco Di Raimondo, M.D., Franco Narni, M.D., Claudia Cellini, M.D., Michela Ceccolini, M.D., Norbert Pescosta, M.D., Maria Cecilia Goldaniga, M.D., Vittorio Montefusco, M.D., Vincenzo Callea, M.D., Valerio De Stefano, M.D., Tommaso Caravita, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 73.
https://doi.org/10.1182/blood.V110.11.73.73
Published: 2007
Journal Articles

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Michele Cavo, MD, Giulia Perrone, M.D., Michela Ceccolini, M.D., Vito Michele Lauta, M.D., Massimo Offidani, M.D., Filippo Ballerini, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Silvana Pasini, M.D., Fausto Dore, M.D., Domenico Vertone, M.D., Paola Tacchetti, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Sante Tura, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 730.
https://doi.org/10.1182/blood.V110.11.730.730
Published: 2007